Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Vaccari

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Nature Communications|February 14, 2024
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kim, Deepanwita Bose, Mariluz Araínga, et al.
AIDS Research and Human Retroviruses|January 18, 2014
Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoirMarcin Moniuszko, Namal P M Liyanage, Melvin N Doster, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kime, Deepanwita Bose, Mariluz Arainga, et al.
Journal of Virology|July 19, 2019
Essential Role of Human T Cell Leukemia Virus Type 1 <i>orf-I</i> in Lethal Proliferation of CD4<sup>+</sup> Cells in Humanized MiceVeronica Galli, Christopher C Nixon, Natasa Strbo, et al.
Scientific Reports|May 19, 2017
E-cigarettes induce toxicological effects that can raise the cancer riskDonatella Canistro, Fabio Vivarelli, Silvia Cirillo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Journal of Virology|November 24, 2012
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPoonam Pegu, Monica Vaccari, Shari Gordon, et al.
Journal of Virology|January 18, 2013
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposureMonica Vaccari, Brandon F Keele, Steven E Bosinger, et al.
Research Square|December 11, 2025
Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaquesTomas R Wiche Salinas, Sienna Freeman, Rebecca Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionTimothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Nature Communications|February 14, 2024
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kim, Deepanwita Bose, Mariluz Araínga, et al.
AIDS Research and Human Retroviruses|January 18, 2014
Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoirMarcin Moniuszko, Namal P M Liyanage, Melvin N Doster, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivoJinhee Kime, Deepanwita Bose, Mariluz Arainga, et al.
Journal of Virology|July 19, 2019
Essential Role of Human T Cell Leukemia Virus Type 1 <i>orf-I</i> in Lethal Proliferation of CD4<sup>+</sup> Cells in Humanized MiceVeronica Galli, Christopher C Nixon, Natasa Strbo, et al.
Scientific Reports|May 19, 2017
E-cigarettes induce toxicological effects that can raise the cancer riskDonatella Canistro, Fabio Vivarelli, Silvia Cirillo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Journal of Virology|November 24, 2012
Antibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialPoonam Pegu, Monica Vaccari, Shari Gordon, et al.
Journal of Virology|January 18, 2013
Protection afforded by an HIV vaccine candidate in macaques depends on the dose of SIVmac251 at challenge exposureMonica Vaccari, Brandon F Keele, Steven E Bosinger, et al.
Research Square|December 11, 2025
Inflammation from mild COVID-19 results in persistent neurological and behavioral changes in rhesus macaquesTomas R Wiche Salinas, Sienna Freeman, Rebecca Richardson, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infectionTimothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
Pageof 9